These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Randomized phase II study of paclitaxel and carboplatin or vinorelbine in advanced non-small cell lung cancer. Jahnke K; Keilholz U; Lüftner D; Thiel E; Schmittel A Anticancer Res; 2011 Jan; 31(1):317-23. PubMed ID: 21273617 [TBL] [Abstract][Full Text] [Related]
5. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results. Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967 [TBL] [Abstract][Full Text] [Related]
6. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer. Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490 [TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment. Stathopoulos GP; Dafni UG; Malamos NA; Rigatos S; Kouvatseas G; Moschopoulos N Anticancer Res; 1999; 19(4C):3543-8. PubMed ID: 10629650 [TBL] [Abstract][Full Text] [Related]
8. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer. Ajlouni M; Chapman R; Kim JH Cancer J Sci Am; 1996; 2(6):314-20. PubMed ID: 9166551 [TBL] [Abstract][Full Text] [Related]
9. Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer. Rice TW; Adelstein DJ; Koka A; Tefft M; Kirby TJ; Van Kirk MA; Taylor ME; Olencki TE; Peereboom D; Budd GT Ann Thorac Surg; 1995 Sep; 60(3):586-91; discussion 591-2. PubMed ID: 7677484 [TBL] [Abstract][Full Text] [Related]
10. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer. Imaizumi M; Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594 [TBL] [Abstract][Full Text] [Related]
11. Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy. Yamazaki S; Sekine I; Matsuno Y; Takei H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T; Kodama T; Asamura H; Tsuchiya R; Saijo N Lung Cancer; 2005 Aug; 49(2):217-23. PubMed ID: 16022916 [TBL] [Abstract][Full Text] [Related]
12. Etoposide plus cisplatin followed by thoracic radiation for stage IIIB non-small cell lung cancer: MAOP study 2188. Lokich J; Auerbach M; Essig L; Fryer J; Fryer D J Infus Chemother; 1995; 5(2):70-2. PubMed ID: 8521238 [TBL] [Abstract][Full Text] [Related]
13. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy. Hainsworth JD; Greco FA Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group. Figlin RA; Crowley JJ; Jacobs EL; Muirhead M; Goodwin JW; Rinehart JJ; Livingston RB Cancer; 1996 Sep; 78(5):998-1003. PubMed ID: 8780537 [TBL] [Abstract][Full Text] [Related]
15. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study. Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041 [TBL] [Abstract][Full Text] [Related]
16. Phase III study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancer. Scagliotti G; Novello S; von Pawel J; Reck M; Pereira JR; Thomas M; Abrão Miziara JE; Balint B; De Marinis F; Keller A; Arén O; Csollak M; Albert I; Barrios CH; Grossi F; Krzakowski M; Cupit L; Cihon F; Dimatteo S; Hanna N J Clin Oncol; 2010 Apr; 28(11):1835-42. PubMed ID: 20212250 [TBL] [Abstract][Full Text] [Related]
17. Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer. Ardizzoni A; Fusco V; Gulisano M; Pronzato P; Baracco F; Capaccio A; Pastorino G; Nosenzo M; Felletti R; Fabiano F Cancer Treat Rep; 1987 Dec; 71(12):1311-2. PubMed ID: 2825994 [No Abstract] [Full Text] [Related]
18. Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer. Pohl G; Krajnik G; Malayeri R; Müller RM; Klepetko W; Eckersberger F; Schäfer-Prokop C; Pokrajac B; Schmeikal S; Maier A; Ambrosch G; Woltsche M; Minar W; Pirker R Lung Cancer; 2006 Oct; 54(1):63-7. PubMed ID: 16926060 [TBL] [Abstract][Full Text] [Related]
19. [Results of a combination of platinum-vindesin-ametycin-bleomycin (CEMB) in the treatment of stage IV non-small-cell lung cancers]. Souquet PJ; Fournel P; Jorda M; Laennec E; Piperno D; Trillet V; Rebattu P; Bernard JP Bull Cancer; 1993 Jan; 80(1):80-2. PubMed ID: 7515730 [TBL] [Abstract][Full Text] [Related]
20. Cisplatin combination chemotherapy induces oxidative stress in advance non small cell lung cancer patients. Srivastava AN; Gupta A; Srivastava S; Natu SM; Mittal B; Negi MP; Prasad R Asian Pac J Cancer Prev; 2010; 11(2):465-71. PubMed ID: 20843135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]